Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant
Por um escritor misterioso
Descrição
Frontiers Recent Advances in Medical Therapy for Urological Cancers
Cancers, Free Full-Text
NICE recommends nivolumab plus ipilimumab for untreated advanced kidney cancer in intermediate or poor-risk patients - ecancer
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies - McGregor - 2021 - Cancer - Wiley Online Library
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial - ScienceDirect
Cancers, Free Full-Text
Immune Checkpoint Blockade for Prostate Cancer: Niche Role or Next Breakthrough?
Castration Resistant Prostate Cancer: Developments & Challenges in 2020
Nivolumab: targeting PD-1 to bolster antitumor immunity
PDF) Long-term complete remission with Ipilimumab in metastatic castrate- resistant prostate cancer: Case report of two patients
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology - ScienceDirect
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
PSMAfore: 177Lu–PSMA-617 in Taxane-Naïve Patients With Metastatic Castration -Resistant Prostate Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
